BOM/543524 (BOM/543524)

Bombay Stock Exchange: BOM/543524 · INR

₹1,206

+8.40 (+0.7%)· Recorded snapshot

Market cap	122.4B
Revenue (ttm)	18.2B
Net income (ttm)	2.9B
EPS (ttm)	₹28.1
P/E (trailing)	42.9x
P/E (forward)	35.4x
Dividend	₹3.50 (0.29%)
Volume	17,958

Market data

Price

Recent price action with selectable time range.

Financial snapshot

Revenue (ttm): 18.2B
Net income (ttm): 2.9B
EPS (ttm): ₹28.1
P/E (trailing): 42.9x
P/E (forward): 35.4x
Market cap: 122.4B

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector percentile context

Refreshed 2026-10-28 19:55 UTC

Forward P/E35.4

P25 n/aP50 n/aP75 n/a

Trailing P/E42.9

P25 n/aP50 n/aP75 n/a

ROE17.9

P25 n/aP50 n/aP75 n/a

ROIC15.8

P25 n/aP50 n/aP75 n/a

Benchmarks · 1M

All BOM/543524 indicators

Market & fundamental data

Available fields

227

Groups with data

Currency

INR

Showing 227 of 227 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Amount currency	INR
Country	India
Country code	IN
Earnings date	2026-11-02
Employees	4,724
Employees change	752
Employees growth	18.93%
Enterprise value	INR 126.5B
Exchange	Bombay Stock Exchange
Financial currency	INR
Financial report date	2026-06-30
First seen	2026-05-10
Fiscal year end	March
Founded	1998
Industry	Medical Care Facilities
Is primary listing	No
ISIN number	INE961O01016
Last earnings date	2026-07-30
Last refreshed	2026-10-28
Market cap	INR 122.4B
Next earnings date	2026-11-02
Price	INR 1,206.15
Price currency	INR
Sector	Healthcare
SIC code	8060
Stock price date	2026-10-28
Symbol	bom/543524
Website	https://www.rainbowhospitals.in

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Adjusted P/E ratio	42.7x
Average P/E ratio (3Y)	55.63x
Average P/E ratio (5Y)	51.03x
Earnings yield	2.33%
EV/Earnings	44.34x
EV/EBIT	30.37x
EV/EBITDA	21.69x
EV/FCF	62.27x
EV/Sales	6.95x
FCF / EV yield	1.61%
FCF yield	1.66%
Forward P/E	35.38x
Graham number	322.1613
Graham upside	-73.29%
Industry forward P/E	41.27x
Industry P/E	63.78x
Lynch fair value	INR 703.27
Lynch upside	-41.69%
P/(FCF - SBC) ratio	61.1x
P/(OCF - SBC) ratio	29.36x
P/B ratio	7.36x
P/E ratio	42.91x
P/FCF ratio	60.22x
P/OCF ratio	29.16x
P/S ratio	6.72x
Price / tangible book value	8.44x
Price/EBITDA ratio	20.98x
Sector forward P/E	36.13x
Sector P/E	45.65x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT margin	22.89%
EBITDA margin	32.05%
Effective tax rate	21.72%
FCF margin	11.93%
Gross margin	72.92%
Operating margin	22.89%
Pretax margin	20.37%
Profit margin	15.68%
Profit per employee	INR 604,141
Profitable quarters	25
Profitable years	8
Revenue per employee	INR 3.9M
ROA	9.55%
ROA (5Y)	10.72%
ROCE	15.21%
ROE	17.94%
ROE (5Y)	21.24%
ROIC	15.78%
ROIC (5Y)	17.93%
SBC / revenue	0.17%
Tax / revenue	4.42%

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
EPS growth	11.46%
EPS growth (Q)	13.28%
EPS growth (QoQ)	-21.34%
EPS growth 3Y	9.97%
EPS growth 5Y	32.75%
EPS growth quarters	3
EPS growth years	5
FCF growth	-18.72%
FCF growth 3Y	2.72%
FCF growth 5Y	24.99%
Gross profit growth	21.01%
Gross profit growth (Q)	33.4%
Gross profit growth 3Y	14.95%
Gross profit growth 5Y	22.34%
Net income growth	10.88%
Net income growth (Q)	13.22%
Net income growth (QoQ)	-21.38%
Net income growth 3Y	10.13%
Net income growth 5Y	34.77%
Net income growth quarters	3
Net income growth years	5
OCF growth	6.07%
OCF growth 3Y	8.47%
OCF growth 5Y	24.08%
Operating income growth	15.3%
Operating income growth (Q)	33.14%
Operating income growth 3Y	10.19%
Operating income growth 5Y	27.17%
Revenue growth	18.3%
Revenue growth (Q)	33.17%
Revenue growth (QoQ)	2.19%
Revenue growth 3Y	14.15%
Revenue growth 5Y	19.67%
Revenue growth quarters	16
Revenue growth years	5

Financial statements

Income-statement and cash-flow amounts, totals and per share.

Metric	Value
Capital expenditures	INR -2.2B
Depreciation and amortization	INR 1.7B
EBIT	INR 4.2B
EBITDA	INR 5.8B
EPS	INR 28.11
Financing cash flow	INR -1.5B
Free cash flow	INR 2B
Free cash flow minus SBC	INR 2B
Gross profit	INR 13.3B
Income taxes	INR 805.3M
Investing cash flow	INR -2.6B
Net borrowing	INR -180M
Net cash flow	INR 136.4M
Net income	INR 2.9B
Operating cash flow minus SBC	INR 4.2B
Operating income	INR 4.2B
Revenue	INR 18.2B
Stock-based compensation	INR 29.1M

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Book value per share	INR 162.36
Debt / EBITDA	1.53
Debt / equity	0.54
Debt / FCF	4.38
Interest coverage	5.16
Net cash (debt)	INR -4B
Net cash / market cap	-3.28%
Net debt / EBITDA	0.69
Net debt / equity	0.24
Net debt / FCF	1.98
Piotroski F-Score	5
Shareholders' equity	INR 16.6B
Tangible book value	INR 14.5B
Tangible book value per share	INR 142.88
Total cash	INR 4.9B
Total debt	INR 8.9B

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Asset turnover	0.66
Current ratio	3.55
Inventory turnover	14.3
Quick ratio	3.18
Working capital	INR 4.8B

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback yield / dilution	0.15%
Dividend growth	16.67%
Dividend growth (3Y)	5.27%
Dividend growth years	0
Dividend payment date	2026-08-27
Dividend payment years	5
Dividend payout frequency	Annual
Dividend per share	INR 3.50
Dividend yield	0.29%
Ex-dividend date	2026-07-21
Last dividend	INR 3.50
Payout ratio	12.45%
Shareholder yield	0.44%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
150-day SMA	INR 1,362.64
1D price change	0.7%
1M price change	-12.18%
1M total return	-12.18%
1W price change	-0.41%
1W total return	-0.41%
1Y price change	-11.29%
1Y return CAGR	-11.08%
1Y total return	-11.08%
20-day SMA	INR 1,239.24
200-day SMA	INR 1,320.74
3M price change	-18.74%
3M total return	-18.74%
3Y price change	6.54%
3Y return CAGR	2.37%
3Y total return	7.29%
50-day SMA	INR 1,360.18
50-day SMA vs 200-day SMA	50over200
52-week high	INR 1,609.00
52-week high date	2026-08-05
52-week low	INR 1,008.75
52-week low date	2026-03-02
6M price change	-3.89%
6M total return	-3.67%
All-time high	INR 1,708.50
All-time high date	2024-11-26
All-time low	INR 410.00
All-time low date	2022-05-17
Average true range (ATR)	INR 38.59
Average volume	22.9K
Change from 52-week high	-25.04%
Change from 52-week low	19.57%
Change from all-time high	-29.4%
Change from all-time low	194.18%
Change from open	1.03%
Day's gap	-0.33%
Dollar volume	INR 21.7M
High price	INR 1,225.10
Low price	INR 1,192.70
Monthly RSI	46.03
Open price	INR 1,193.80
Position in 52-week range	41.51%
Previous close	INR 1,197.75
Price vs 150-day SMA	-11.48%
Price vs 20-day SMA	-2.67%
Price vs 200-day SMA	-8.68%
Price vs 50-day SMA	-11.32%
Relative volume	0.81
RSI	35.48
Sharpe ratio	-0.5
Sharpe ratio (3Y)	0.17
Sortino ratio	-0.47
Sortino ratio (3Y)	0.46
Volume	18K
Weekly RSI	36.76
YTD price change	-8.6%
YTD total return	-8.39%

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	48.8M
Shares change (QoQ)	-0.04%
Shares change (YoY)	-0.15%
Shares held by insiders	45.83%
Shares held by institutions	40.71%

Deeper analysis on BOM/543524

14 sections in the full report · jump straight to what you need

Forecast

Base and Bull forecast paths with report-date return framing.

→

Valuation

Fair-value bridge, DCF, owner earnings, and peer multiples.

→

Sensitivity

Cost-of-equity and terminal-growth stress table.

→

Risks

Kill scenarios, soft-pass flags, and downside catalysts.

→

Earnings

Next earnings setup and beat / inline / miss thresholds.

→

Position sizing

Entry, exit, conviction, and quarterly monitoring rules.

→

Financials

Revenue, margins, cash flow, and balance-sheet context.

→

Peers

Relative valuation and profitability against the cohort.

→

Moat

Economic-profit evidence and competitive advantage risk.

→

Industry cycle

Sector phase, capital cycle, and secular tailwinds.

→

Frequently asked questions

About this BOM/543524 report

Is a complete BOM/543524 research report available?

No complete published report is available for bom/543524 (BOM/543524) on this page. Market-directory data, when present, is not a substitute for a validated stock analysis.

BOM/543524 (BOM/543524)

Price

Financial snapshot

Fair-value bridge

Latest news · BOM/543524

Valuation

Profitability

Balance sheet

Trading

Next earnings

Sector percentile context

All BOM/543524 indicators

Profile and market data

Valuation

Profitability

Growth

Financial statements

Financial strength

Liquidity

Dividends and buybacks

Performance and technicals

Ownership and float

Deeper analysis on BOM/543524

Frequently asked questions